BioSpace News Archive

Solidifying Discovery’s Role as a Leader in Long Read Sequencing and Creating Large-Scale Long Read and Short Read Sequencing Services

Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients who have high unmet medical need conditions, today announces it will host a conference call and live webcast on Nov. 12, 2020, at 5:30 p.m. Eastern time to discuss its third quarter 2020 results and provide an update on the Company’s

Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co , a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., today announced it has signed distribution agreements for its GenViro Covid-19 Kits

New Jersey Brain and Spine (NJBS), the region’s leading brain and spine surgery group, is proud to announce that Timothy Vogel, M.D., Ph.D., the practice’s director of pediatric neurosurgery, has cofounded a new laboratory for pediatric neuro-oncology with Derek Hanson, M.D., at the Center for Discovery and Innovation (CDI) at Hackensack University Medical Center (HUMC).

Alzamend Neuro®, Inc. (“Alzamend®” or the “Company”) announced today that the Company will host a conference call and webcast led by its Founder and Chairman, Milton “Todd” Ault, III, and Stephan Jackman, Company’s CEO and Director, on Tuesday, November 17th at 5:00pm ET (2:00pm PT)

Qosina is pleased to carry a variety of SmartSite™ swabbable needle-free injection sites . Featuring an ergonomic design and a smooth, flat top that can be easily disinfected, these components are equipped with a valve, that when activated, forms an airtight seal between the male luer and the top of the blue piston of the valve. This helps to prevent air bubbles or fluid leakage. The straight-through fluid path is equiv

American Injectables Inc., a manufacturer of sterile injectable parenteral drugs located near Tampa Bay, FL, today announced the hiring of Benjamin Boling as its Chief Operating Officer.

Joline Medical LLC and Joline GmbH & CO. KG announce that the companies have performed the first United States case utilizing Joline’s Stop’n GO Double Balloon Catheter (Quattroplasty®) products to treat vertebral compression fractures

Confidio, a technology-enabled pharmacy benefits consulting firm has completed its annual update of the Confidio RED ™ List. The Confidio RED List was launched in 2019 to empower plan sponsors to counteract drugs that drive

Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced presentation of body composition data from the Company’s Phase III trial, DESTINY PWS (C601), evaluating once-daily Diazoxide Choline Controlled Release (DCCR) tablets for patients with Prader-Willi Syndrome (PWS).